Zobrazeno 1 - 10
of 73
pro vyhledávání: '"Yoshiyuki, Sawai"'
Autor:
Yoshihiro Kamada, Takashi Nakahara, Kensuke Munekage, Hideki Fujii, Yoshiyuki Sawai, Yoshinori Doi, Masafumi Ono, Hideyuki Hyogo, Yoshio Sumida, Koichi Morishita, Tatsuya Asuka, Tsunenori Ouchida, Yasuharu Imai, Eiji Miyoshi, Japan Study Group of NAFLD
Publikováno v:
Hepatology Communications, Vol 6, Iss 7, Pp 1527-1536 (2022)
Abstract We previously demonstrated that Mac‐2 binding protein (M2BP) is a useful biomarker for nonalcoholic fatty liver disease (NAFLD), particularly NAFLD fibrosis prediction. In the present study, we investigated the prognostic value of M2BP in
Externí odkaz:
https://doaj.org/article/e4ff53598d6b40ab88a92716feb59529
Autor:
Yoshihiro Kamada, Kensuke Munekage, Takashi Nakahara, Hideki Fujii, Yoshiyuki Sawai, Yoshinori Doi, Hideyuki Hyogo, Yoshio Sumida, Yasuharu Imai, Eiji Miyoshi, Masafumi Ono
Publikováno v:
Nutrients, Vol 15, Iss 1, p 66 (2022)
The prognosis of nonalcoholic fatty liver disease (NAFLD) patients depends on liver-related events (LREs), extrahepatic cancers, and major adverse cardiovascular events (MACEs). The fibrosis-4 (FIB-4) index is one of the most reliable and useful pred
Externí odkaz:
https://doaj.org/article/ea6a2554b85848db9fbacb5a004ef783
Autor:
Yoshiyuki Sawai, Takumi Igura, Yasuharu Imai, Yoshihiro Yukimura, Kazuto Fukuda, Norihiko Fujita, Masahide Oshita, Sachiyo Kogiata, Yasushi Seki, Emi Meren
Publikováno v:
GastroHep. 3:435-442
Autor:
Takayuki Matsumae, Takahiro Kodama, Yuta Myojin, Kazuki Maesaka, Ryotaro Sakamori, Ayako Takuwa, Keiko Oku, Daisuke Motooka, Yoshiyuki Sawai, Masahide Oshita, Tasuku Nakabori, Kazuyoshi Ohkawa, Masanori Miyazaki, Satoshi Tanaka, Eiji Mita, Seiichi Tawara, Takayuki Yakushijin, Yasutoshi Nozaki, Hideki Hagiwara, Yuki Tahata, Ryoko Yamada, Hayato Hikita, Tomohide Tatsumi, Tetsuo Takehara
Publikováno v:
Cancers; Volume 14; Issue 14; Pages: 3367
Combination immunotherapy with anti-programmed cell death1-ligand1 (PD-L1) and anti-vascular endothelial growth factor (VEGF) antibodies has become the standard treatment for patients with unresectable HCC (u-HCC). However, limited patients obtain cl
Autor:
null Emi Meren, null Yoshiyuki Sawai, null Kazuto Fukuda, null Takumi Igura, null Sachiyo Kogiata, null Yoshihiro Yukimura, null Yasushi Seki, null Norihiko Fujita, null Masahide Oshita, null Yasuharu Imai
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a5caf5248e961f70e931cce1ce2dbfa3
https://doi.org/10.1002/ygh2.495/v2/response1
https://doi.org/10.1002/ygh2.495/v2/response1
Autor:
Yoshinobu Sato, Takashi Ota, Yoshito Otake, Yasuharu Imai, Masatoshi Hori, Mazen Soufi, Yoshiyuki Sawai, Kazuya Moriguchi, Noriyuki Tomiyama
Publikováno v:
International Journal of Computer Assisted Radiology and Surgery. 14:2083-2093
Liver shape variations have been considered as feasible indicators of liver fibrosis. However, current statistical shape models (SSM) based on principal component analysis represent gross shape variations without considering the association with the
Autor:
Yoshihiro Kamada, Maaya Akita, Yuri Takeda, Shin Yamada, Hideki Fujii, Yoshiyuki Sawai, Yoshinori Doi, Hitomi Asazawa, Kotarosumitomo Nakayama, Kayo Mizutani, Hironobu Fujii, Takayuki Yakushijin, Masanori Miyazaki, Hisao Ezaki, Naoki Hiramatsu, Yuichi Yoshida, Shinichi Kiso, Yasuharu Imai, Norifumi Kawada, Tetsuo Takehara, Eiji Miyoshi
Publikováno v:
PLoS ONE, Vol 8, Iss 6, p e66328 (2013)
Nonalcoholic fatty liver disease (NAFLD) is a growing medical problem around the world. NAFLD patients with nonalcoholic steatohepatitis (NASH) can develop cirrhosis and hepatocellular carcinoma. The ability to distinguish NASH from simple steatosis
Externí odkaz:
https://doaj.org/article/94493805052345049b4451e8919f156c
Autor:
Sachiyo Kogita, Hiromi Shimakoshi, Yoshitaka Yamaguchi, Kazuto Fukuda, Osakuni Morimoto, Yasuharu Imai, Kazuma Daiku, Takumi Igura, Daisuke Takiuchi, Masanori Nakahara, Yoshiyuki Sawai, Kunitaka Shibata, Tadashi Kegasawa
Publikováno v:
Clinical journal of gastroenterology. 13(6)
Primary sclerosing cholangitis (PSC) is associated with significant risk for hepatobiliary cancers. Primary hepatic adenosquamous carcinoma (ASC), a rare subtype of cholangiocarcinoma, is composed of both adenocarcinoma and squamous cell carcinoma co
Autor:
Ayaka Deguchi, Yosuke Yamagata, Yasuhisa Shinomura, Hiroshi Ohashi, Takayuki Iwamoto, Masanori Nakahara, Syunta Kamimura, Kazuto Fukuda, Chie Koh, Yasushi Matsumoto, Junya Okabe, Yoshitaka Yamaguchi, Masahiro Kira, Sachiyo Kogita, Yasuharu Imai, Ryuya Aisaka, Takumi Igura, Yoshiyuki Sawai
Publikováno v:
Kanzo. 58:248-254
Autor:
Norihiko Fujita, Yasuharu Imai, Sachiyo Kogita, Takumi Igura, Hiroshi Ohashi, Masanori Nakahara, Yasushi Matsumoto, Yoshitaka Yamaguchi, Osakuni Morimoto, Takayuki Iwamoto, Tetsuo Takehara, Yoshiyuki Sawai, Masatoshi Kudo, Kazuto Fukuda
Publikováno v:
Digestive Diseases. 35:574-582
Background: Non-hypervascular hypointense hepatic nodules during the hepatobiliary phase of gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid (Gd-EOB-DTPA)-enhanced MRI have been reported to be associated with intrahepatic distant recurrenc